About the RAPID project
The project's goals and methods
UK Genetic Testing Network (UKGTN) gene dossier submitted for approval for Apert syndrome and paternal exclusion of the cystic fibrosis altered gene.
UKGTN approved NIPD for achondroplasia and thanatophoric dysplasia.
UKGTN approved NIPD for fetal sex determination.